BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21813470)

  • 1. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
    Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
    Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
    PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.
    Wei JH; Cao JZ; Zhang D; Liao B; Zhong WM; Lu J; Zhao HW; Zhang JX; Tong ZT; Fan S; Liang CZ; Liao YB; Pang J; Wu RH; Fang Y; Chen ZH; Li B; Xie D; Chen W; Luo JH
    Br J Cancer; 2014 Apr; 110(7):1767-77. PubMed ID: 24504366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative way for epithelial-to-mesenchymal transition in colorectal cancer via EIF5A2?
    Kolligs FT
    Gut; 2012 Apr; 61(4):473-4. PubMed ID: 22180060
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].
    Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells.
    Tuncay Cagatay S; Cimen I; Savas B; Banerjee S
    Tumour Biol; 2013 Apr; 34(2):1189-204. PubMed ID: 23371285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1.
    Chen WH; Cai MY; Zhang JX; Wang FW; Tang LQ; Liao YJ; Jin XH; Wang CY; Guo L; Jiang YG; Ren CP; Mai HQ; Zeng MS; Kung HF; Qian CN; Xie D
    Oncogene; 2018 Nov; 37(48):6243-6258. PubMed ID: 30013189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.
    Li J; Ye L; Sun PH; Satherley L; Hargest R; Zhang Z; Jiang WG
    Cancer Genomics Proteomics; 2015; 12(6):339-45. PubMed ID: 26543080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-421 inhibited proliferation and metastasis of colorectal cancer by targeting MTA1.
    Xue L; Yang D
    J BUON; 2018; 23(6):1633-1639. PubMed ID: 30610787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
    Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
    Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTA1 promotes metastasis of MPM via suppression of E-cadherin.
    Xu C; Hua F; Chen Y; Huang H; Ye W; Yu Y; Shen Z
    J Exp Clin Cancer Res; 2015 Dec; 34():151. PubMed ID: 26689197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer.
    Zhang H; Zhang K; Ning L; Chen D; Hao F; Li P
    Bioengineered; 2020 Dec; 11(1):1325-1333. PubMed ID: 33200656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.